Newsmeme!
Discover News you didn't know existed
Cytokine
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Neuro Products India launches InterX 1000 for pain management
Published July 5, 2009, 7:49 pm, PharmaBiz
Neuro Products India, which is the official distributor for the US-based Neuro Resource Group (NRG) has now made available the new InterX 1000 pain management device. The product which is a part of the home health technologies can be used by patients or carried by physiotherapists for home visits.
Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus
Published July 5, 2009, 11:23 am, Nature
Cohesin-mediated sister chromatid cohesion is essential for chromosome segregation and post-replicative DNA repair. In addition, evidence from model organisms and from human genetics suggests that cohesin is involved in the control of gene expression. This non-canonical role has recently been rationalized by the findings that mammalian cohesin complexes are recruited to a subset of DNase I ...
Deadly Leukemia Stem Cells Found And Eliminated By New Targeted Therapy
Published July 4, 2009, 3:09 am, Medical News Today
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer.
Novel targeted therapy shows promise to eliminate leukaemia stem cells
Published July 3, 2009, 1:03 am, New Kerala
Washington, July 3 : A piece of research has shown that it is possible to eliminate stem cells related to human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer, using a new targeted therapy.
New Targeted Therapy Finds And Eliminates Deadly Leukemia Stem Cells
Published July 2, 2009, 9:23 pm, Science Daily
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia, a notoriously treatment-resistant blood cancer. The study describes exciting preclinical studies in which a new therapeutic approach selectively attacks human cancer cells grown in the lab and in animal models of leukemia.
New targeted therapy finds and eliminates deadly leukemia stem cells
Published July 2, 2009, 9:33 am, PhysOrg
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer. The study, published by Cell Press in the July 2nd issue of the journal Cell Stem Cell, describes exciting preclinical studies in which a new therapeutic approach selectively attacks human cancer cells grown in the lab and in ...
Research Identifies Biomarker That Safely Monitors Tumor Response To New Brain Cancer Treatment
Published July 1, 2009, 8:30 am, redOrbit
Gene therapy technique developed in animal model by Cedars-Sinai research team uses immune cells to attack glioblastoma multiformeA specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme.
Biomarker That Safely Monitors Tumor Response To New Brain Cancer Treatment
Published July 1, 2009, 7:20 am, Science Daily
A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme.
Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
Published July 1, 2009, 3:18 am, PhysOrg
A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. The finding, reported in the July 1 issue of Clinical Cancer Research, paves the way for a Phase 1 clinical trial expected to begin in late 2009.
Study Identifies Biomarker That Safely Monitors Tumor Response to New Brain Cancer Treatment; Paves the Way to Phase 1 ...
Published June 30, 2009, 9:34 pm, Newswise
A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma multiforme. The finding, reported in the July 1 issue of Clinical Cancer Research, paves the way for a Phase 1 clinical trial expected to begin in late 2009.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |